(Bloomberg) — Eastman Kodak Co. shares more than tripled Tuesday on a $765 million government loan to help produce ingredients used in key generic medicines to fight the coronavirus.The development bank loan is the first of its kind under the Defense Production Act in collaboration with the U.S. Department of Defense. It’s intended to speed production of drugs in short supply and those considered critical to treat Covid-19, which may include hydroxychloroquine, the controversial antimalarial drug touted by President Donald Trump.The money could provide a lifeline to Kodak, the storied photography giant whose business and shares were devastated by the …read more
Source:: Yahoo Finance
